Clinical Trials · NCT04854083
Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Kirsi Pietiläinen
- Enrollment
- 50
- Start date
- Feb 2022
- Locations
- 1 site, Finland
- Primary endpoint
- HbA1c